开云app官网登录入口网页版-官方正版

[GetPortalCommentsPageByObjectIdResponse(id=2184987, encodeId=377f218498e43, content=审稿速度:2.0 经验分享：什么时候有影响因子？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4d7d70412, createdName=15014e5643m, createdTime=Wed Jan 31 08:57:19 CST 2024, time=2024-01-31, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2131150, encodeId=192b213115024, content=11, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220127/d05bb6afae5547958d72f7f748779d3a/82871b0a56864780a70e9106d8e05ac0.jpg, createdBy=68215628101, createdName=ms3000000528368992, createdTime=Tue May 09 15:04:56 CST 2023, time=2023-05-09, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2117195, encodeId=b134211e1958c, content=感觉是内部特供，有成功的先例嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a82b5450835, createdName=osmataku, createdTime=Thu Mar 02 11:04:51 CST 2023, time=2023-03-02, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2096628, encodeId=8d6c2096628dd, content=审稿速度:2.0 | 投稿命中率:95.0 经验分享：点赞, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=220, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=90fb5469612, createdName=哈哈哈111, createdTime=Fri Oct 28 10:30:33 CST 2022, time=2022-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226380, encodeId=61371226380ba, content=目前大都是nejm的transfer文章, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=438, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a82b5450835, createdName=osmataku, createdTime=Tue Jun 14 14:04:48 CST 2022, time=2022-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1240257, encodeId=3971124025ea7, content=收不收meta分析啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=323, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5e7a5327063, createdName=148bf3b8m15暂无昵称, createdTime=Mon Aug 22 12:06:29 CST 2022, time=2022-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1240764, encodeId=8f871240e6480, content=厉害, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=343, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d816523541, createdName=ms7000000945555678, createdTime=Wed Aug 24 19:00:01 CST 2022, time=2022-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1239647, encodeId=d99b123964e36, content=稿费可观吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=319, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ba988244399, createdName=兰医生, createdTime=Fri Aug 19 05:07:27 CST 2022, time=2022-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207962, encodeId=ebdf120e962bf, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：meta分析;医学综合;临床试验 经验分享：这是NEJM旗下的新刊，刚刚出版，不过因为NEJM这个高贵血统，估计会有不少文章投NEJM后建议转投到这里。初步看了一些文章，质量还是相当不错的，未来估计影响因子在10-20分之间，不要因为现在没有IF就不投了，毕竟是名门贵族！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=421, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=医者仁者, createdTime=Fri Apr 01 21:27:28 CST 2022, time=2022-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233662, encodeId=c05112336621d, content=eee, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=345, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220719/78e45345e7a54aa7965f216022201f0f/f7c753494cda4f2f866bc9105db59a65.png, createdBy=155c5510995, createdName=YaliMei, createdTime=Wed Jul 20 17:07:54 CST 2022, time=2022-07-20, status=1, ipAttribution=)]

2024-01-31 15014e5643m 来自重庆

审稿速度:2.0
经验分享：什么时候有影响因子？

77 0

[GetPortalCommentsPageByObjectIdResponse(id=2184987, encodeId=377f218498e43, content=审稿速度:2.0 经验分享：什么时候有影响因子？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4d7d70412, createdName=15014e5643m, createdTime=Wed Jan 31 08:57:19 CST 2024, time=2024-01-31, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2131150, encodeId=192b213115024, content=11, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220127/d05bb6afae5547958d72f7f748779d3a/82871b0a56864780a70e9106d8e05ac0.jpg, createdBy=68215628101, createdName=ms3000000528368992, createdTime=Tue May 09 15:04:56 CST 2023, time=2023-05-09, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2117195, encodeId=b134211e1958c, content=感觉是内部特供，有成功的先例嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a82b5450835, createdName=osmataku, createdTime=Thu Mar 02 11:04:51 CST 2023, time=2023-03-02, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2096628, encodeId=8d6c2096628dd, content=审稿速度:2.0 | 投稿命中率:95.0 经验分享：点赞, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=220, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=90fb5469612, createdName=哈哈哈111, createdTime=Fri Oct 28 10:30:33 CST 2022, time=2022-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226380, encodeId=61371226380ba, content=目前大都是nejm的transfer文章, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=438, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a82b5450835, createdName=osmataku, createdTime=Tue Jun 14 14:04:48 CST 2022, time=2022-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1240257, encodeId=3971124025ea7, content=收不收meta分析啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=323, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5e7a5327063, createdName=148bf3b8m15暂无昵称, createdTime=Mon Aug 22 12:06:29 CST 2022, time=2022-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1240764, encodeId=8f871240e6480, content=厉害, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=343, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d816523541, createdName=ms7000000945555678, createdTime=Wed Aug 24 19:00:01 CST 2022, time=2022-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1239647, encodeId=d99b123964e36, content=稿费可观吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=319, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ba988244399, createdName=兰医生, createdTime=Fri Aug 19 05:07:27 CST 2022, time=2022-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207962, encodeId=ebdf120e962bf, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：meta分析;医学综合;临床试验 经验分享：这是NEJM旗下的新刊，刚刚出版，不过因为NEJM这个高贵血统，估计会有不少文章投NEJM后建议转投到这里。初步看了一些文章，质量还是相当不错的，未来估计影响因子在10-20分之间，不要因为现在没有IF就不投了，毕竟是名门贵族！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=421, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=医者仁者, createdTime=Fri Apr 01 21:27:28 CST 2022, time=2022-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233662, encodeId=c05112336621d, content=eee, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=345, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220719/78e45345e7a54aa7965f216022201f0f/f7c753494cda4f2f866bc9105db59a65.png, createdBy=155c5510995, createdName=YaliMei, createdTime=Wed Jul 20 17:07:54 CST 2022, time=2022-07-20, status=1, ipAttribution=)]

2023-05-09 ms3000000528368992 来自上海

11

119 0

[GetPortalCommentsPageByObjectIdResponse(id=2184987, encodeId=377f218498e43, content=审稿速度:2.0 经验分享：什么时候有影响因子？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4d7d70412, createdName=15014e5643m, createdTime=Wed Jan 31 08:57:19 CST 2024, time=2024-01-31, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2131150, encodeId=192b213115024, content=11, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220127/d05bb6afae5547958d72f7f748779d3a/82871b0a56864780a70e9106d8e05ac0.jpg, createdBy=68215628101, createdName=ms3000000528368992, createdTime=Tue May 09 15:04:56 CST 2023, time=2023-05-09, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2117195, encodeId=b134211e1958c, content=感觉是内部特供，有成功的先例嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a82b5450835, createdName=osmataku, createdTime=Thu Mar 02 11:04:51 CST 2023, time=2023-03-02, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2096628, encodeId=8d6c2096628dd, content=审稿速度:2.0 | 投稿命中率:95.0 经验分享：点赞, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=220, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=90fb5469612, createdName=哈哈哈111, createdTime=Fri Oct 28 10:30:33 CST 2022, time=2022-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226380, encodeId=61371226380ba, content=目前大都是nejm的transfer文章, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=438, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a82b5450835, createdName=osmataku, createdTime=Tue Jun 14 14:04:48 CST 2022, time=2022-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1240257, encodeId=3971124025ea7, content=收不收meta分析啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=323, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5e7a5327063, createdName=148bf3b8m15暂无昵称, createdTime=Mon Aug 22 12:06:29 CST 2022, time=2022-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1240764, encodeId=8f871240e6480, content=厉害, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=343, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d816523541, createdName=ms7000000945555678, createdTime=Wed Aug 24 19:00:01 CST 2022, time=2022-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1239647, encodeId=d99b123964e36, content=稿费可观吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=319, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ba988244399, createdName=兰医生, createdTime=Fri Aug 19 05:07:27 CST 2022, time=2022-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207962, encodeId=ebdf120e962bf, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：meta分析;医学综合;临床试验 经验分享：这是NEJM旗下的新刊，刚刚出版，不过因为NEJM这个高贵血统，估计会有不少文章投NEJM后建议转投到这里。初步看了一些文章，质量还是相当不错的，未来估计影响因子在10-20分之间，不要因为现在没有IF就不投了，毕竟是名门贵族！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=421, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=医者仁者, createdTime=Fri Apr 01 21:27:28 CST 2022, time=2022-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233662, encodeId=c05112336621d, content=eee, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=345, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220719/78e45345e7a54aa7965f216022201f0f/f7c753494cda4f2f866bc9105db59a65.png, createdBy=155c5510995, createdName=YaliMei, createdTime=Wed Jul 20 17:07:54 CST 2022, time=2022-07-20, status=1, ipAttribution=)]

2023-03-02 osmataku 来自北京

感觉是内部特供，有成功的先例嘛

123 0

[GetPortalCommentsPageByObjectIdResponse(id=2184987, encodeId=377f218498e43, content=审稿速度:2.0 经验分享：什么时候有影响因子？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4d7d70412, createdName=15014e5643m, createdTime=Wed Jan 31 08:57:19 CST 2024, time=2024-01-31, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2131150, encodeId=192b213115024, content=11, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220127/d05bb6afae5547958d72f7f748779d3a/82871b0a56864780a70e9106d8e05ac0.jpg, createdBy=68215628101, createdName=ms3000000528368992, createdTime=Tue May 09 15:04:56 CST 2023, time=2023-05-09, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2117195, encodeId=b134211e1958c, content=感觉是内部特供，有成功的先例嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a82b5450835, createdName=osmataku, createdTime=Thu Mar 02 11:04:51 CST 2023, time=2023-03-02, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2096628, encodeId=8d6c2096628dd, content=审稿速度:2.0 | 投稿命中率:95.0 经验分享：点赞, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=220, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=90fb5469612, createdName=哈哈哈111, createdTime=Fri Oct 28 10:30:33 CST 2022, time=2022-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226380, encodeId=61371226380ba, content=目前大都是nejm的transfer文章, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=438, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a82b5450835, createdName=osmataku, createdTime=Tue Jun 14 14:04:48 CST 2022, time=2022-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1240257, encodeId=3971124025ea7, content=收不收meta分析啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=323, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5e7a5327063, createdName=148bf3b8m15暂无昵称, createdTime=Mon Aug 22 12:06:29 CST 2022, time=2022-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1240764, encodeId=8f871240e6480, content=厉害, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=343, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d816523541, createdName=ms7000000945555678, createdTime=Wed Aug 24 19:00:01 CST 2022, time=2022-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1239647, encodeId=d99b123964e36, content=稿费可观吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=319, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ba988244399, createdName=兰医生, createdTime=Fri Aug 19 05:07:27 CST 2022, time=2022-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207962, encodeId=ebdf120e962bf, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：meta分析;医学综合;临床试验 经验分享：这是NEJM旗下的新刊，刚刚出版，不过因为NEJM这个高贵血统，估计会有不少文章投NEJM后建议转投到这里。初步看了一些文章，质量还是相当不错的，未来估计影响因子在10-20分之间，不要因为现在没有IF就不投了，毕竟是名门贵族！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=421, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=医者仁者, createdTime=Fri Apr 01 21:27:28 CST 2022, time=2022-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233662, encodeId=c05112336621d, content=eee, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=345, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220719/78e45345e7a54aa7965f216022201f0f/f7c753494cda4f2f866bc9105db59a65.png, createdBy=155c5510995, createdName=YaliMei, createdTime=Wed Jul 20 17:07:54 CST 2022, time=2022-07-20, status=1, ipAttribution=)]

2022-10-28 哈哈哈111

审稿速度:2.0 | 投稿命中率:95.0
经验分享：点赞

220 0

[GetPortalCommentsPageByObjectIdResponse(id=2184987, encodeId=377f218498e43, content=审稿速度:2.0 经验分享：什么时候有影响因子？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4d7d70412, createdName=15014e5643m, createdTime=Wed Jan 31 08:57:19 CST 2024, time=2024-01-31, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2131150, encodeId=192b213115024, content=11, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220127/d05bb6afae5547958d72f7f748779d3a/82871b0a56864780a70e9106d8e05ac0.jpg, createdBy=68215628101, createdName=ms3000000528368992, createdTime=Tue May 09 15:04:56 CST 2023, time=2023-05-09, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2117195, encodeId=b134211e1958c, content=感觉是内部特供，有成功的先例嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a82b5450835, createdName=osmataku, createdTime=Thu Mar 02 11:04:51 CST 2023, time=2023-03-02, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2096628, encodeId=8d6c2096628dd, content=审稿速度:2.0 | 投稿命中率:95.0 经验分享：点赞, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=220, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=90fb5469612, createdName=哈哈哈111, createdTime=Fri Oct 28 10:30:33 CST 2022, time=2022-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226380, encodeId=61371226380ba, content=目前大都是nejm的transfer文章, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=438, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a82b5450835, createdName=osmataku, createdTime=Tue Jun 14 14:04:48 CST 2022, time=2022-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1240257, encodeId=3971124025ea7, content=收不收meta分析啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=323, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5e7a5327063, createdName=148bf3b8m15暂无昵称, createdTime=Mon Aug 22 12:06:29 CST 2022, time=2022-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1240764, encodeId=8f871240e6480, content=厉害, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=343, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d816523541, createdName=ms7000000945555678, createdTime=Wed Aug 24 19:00:01 CST 2022, time=2022-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1239647, encodeId=d99b123964e36, content=稿费可观吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=319, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ba988244399, createdName=兰医生, createdTime=Fri Aug 19 05:07:27 CST 2022, time=2022-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207962, encodeId=ebdf120e962bf, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：meta分析;医学综合;临床试验 经验分享：这是NEJM旗下的新刊，刚刚出版，不过因为NEJM这个高贵血统，估计会有不少文章投NEJM后建议转投到这里。初步看了一些文章，质量还是相当不错的，未来估计影响因子在10-20分之间，不要因为现在没有IF就不投了，毕竟是名门贵族！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=421, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=医者仁者, createdTime=Fri Apr 01 21:27:28 CST 2022, time=2022-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233662, encodeId=c05112336621d, content=eee, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=345, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220719/78e45345e7a54aa7965f216022201f0f/f7c753494cda4f2f866bc9105db59a65.png, createdBy=155c5510995, createdName=YaliMei, createdTime=Wed Jul 20 17:07:54 CST 2022, time=2022-07-20, status=1, ipAttribution=)]

2022-06-14 osmataku

目前大都是nejm的transfer文章

438 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2184987, encodeId=377f218498e43, content=审稿速度:2.0 经验分享：什么时候有影响因子？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4d7d70412, createdName=15014e5643m, createdTime=Wed Jan 31 08:57:19 CST 2024, time=2024-01-31, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2131150, encodeId=192b213115024, content=11, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220127/d05bb6afae5547958d72f7f748779d3a/82871b0a56864780a70e9106d8e05ac0.jpg, createdBy=68215628101, createdName=ms3000000528368992, createdTime=Tue May 09 15:04:56 CST 2023, time=2023-05-09, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2117195, encodeId=b134211e1958c, content=感觉是内部特供，有成功的先例嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a82b5450835, createdName=osmataku, createdTime=Thu Mar 02 11:04:51 CST 2023, time=2023-03-02, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2096628, encodeId=8d6c2096628dd, content=审稿速度:2.0 | 投稿命中率:95.0 经验分享：点赞, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=220, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=90fb5469612, createdName=哈哈哈111, createdTime=Fri Oct 28 10:30:33 CST 2022, time=2022-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226380, encodeId=61371226380ba, content=目前大都是nejm的transfer文章, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=438, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a82b5450835, createdName=osmataku, createdTime=Tue Jun 14 14:04:48 CST 2022, time=2022-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1240257, encodeId=3971124025ea7, content=收不收meta分析啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=323, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5e7a5327063, createdName=148bf3b8m15暂无昵称, createdTime=Mon Aug 22 12:06:29 CST 2022, time=2022-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1240764, encodeId=8f871240e6480, content=厉害, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=343, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d816523541, createdName=ms7000000945555678, createdTime=Wed Aug 24 19:00:01 CST 2022, time=2022-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1239647, encodeId=d99b123964e36, content=稿费可观吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=319, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ba988244399, createdName=兰医生, createdTime=Fri Aug 19 05:07:27 CST 2022, time=2022-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207962, encodeId=ebdf120e962bf, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：meta分析;医学综合;临床试验 经验分享：这是NEJM旗下的新刊，刚刚出版，不过因为NEJM这个高贵血统，估计会有不少文章投NEJM后建议转投到这里。初步看了一些文章，质量还是相当不错的，未来估计影响因子在10-20分之间，不要因为现在没有IF就不投了，毕竟是名门贵族！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=421, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=医者仁者, createdTime=Fri Apr 01 21:27:28 CST 2022, time=2022-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233662, encodeId=c05112336621d, content=eee, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=345, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220719/78e45345e7a54aa7965f216022201f0f/f7c753494cda4f2f866bc9105db59a65.png, createdBy=155c5510995, createdName=YaliMei, createdTime=Wed Jul 20 17:07:54 CST 2022, time=2022-07-20, status=1, ipAttribution=)]

2022-08-22 148bf3b8m15暂无昵称

收不收meta分析啊

323 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2184987, encodeId=377f218498e43, content=审稿速度:2.0 经验分享：什么时候有影响因子？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4d7d70412, createdName=15014e5643m, createdTime=Wed Jan 31 08:57:19 CST 2024, time=2024-01-31, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2131150, encodeId=192b213115024, content=11, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220127/d05bb6afae5547958d72f7f748779d3a/82871b0a56864780a70e9106d8e05ac0.jpg, createdBy=68215628101, createdName=ms3000000528368992, createdTime=Tue May 09 15:04:56 CST 2023, time=2023-05-09, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2117195, encodeId=b134211e1958c, content=感觉是内部特供，有成功的先例嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a82b5450835, createdName=osmataku, createdTime=Thu Mar 02 11:04:51 CST 2023, time=2023-03-02, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2096628, encodeId=8d6c2096628dd, content=审稿速度:2.0 | 投稿命中率:95.0 经验分享：点赞, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=220, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=90fb5469612, createdName=哈哈哈111, createdTime=Fri Oct 28 10:30:33 CST 2022, time=2022-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226380, encodeId=61371226380ba, content=目前大都是nejm的transfer文章, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=438, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a82b5450835, createdName=osmataku, createdTime=Tue Jun 14 14:04:48 CST 2022, time=2022-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1240257, encodeId=3971124025ea7, content=收不收meta分析啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=323, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5e7a5327063, createdName=148bf3b8m15暂无昵称, createdTime=Mon Aug 22 12:06:29 CST 2022, time=2022-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1240764, encodeId=8f871240e6480, content=厉害, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=343, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d816523541, createdName=ms7000000945555678, createdTime=Wed Aug 24 19:00:01 CST 2022, time=2022-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1239647, encodeId=d99b123964e36, content=稿费可观吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=319, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ba988244399, createdName=兰医生, createdTime=Fri Aug 19 05:07:27 CST 2022, time=2022-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207962, encodeId=ebdf120e962bf, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：meta分析;医学综合;临床试验 经验分享：这是NEJM旗下的新刊，刚刚出版，不过因为NEJM这个高贵血统，估计会有不少文章投NEJM后建议转投到这里。初步看了一些文章，质量还是相当不错的，未来估计影响因子在10-20分之间，不要因为现在没有IF就不投了，毕竟是名门贵族！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=421, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=医者仁者, createdTime=Fri Apr 01 21:27:28 CST 2022, time=2022-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233662, encodeId=c05112336621d, content=eee, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=345, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220719/78e45345e7a54aa7965f216022201f0f/f7c753494cda4f2f866bc9105db59a65.png, createdBy=155c5510995, createdName=YaliMei, createdTime=Wed Jul 20 17:07:54 CST 2022, time=2022-07-20, status=1, ipAttribution=)]

2022-08-24 ms7000000945555678

厉害

343 0

[GetPortalCommentsPageByObjectIdResponse(id=2184987, encodeId=377f218498e43, content=审稿速度:2.0 经验分享：什么时候有影响因子？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4d7d70412, createdName=15014e5643m, createdTime=Wed Jan 31 08:57:19 CST 2024, time=2024-01-31, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2131150, encodeId=192b213115024, content=11, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220127/d05bb6afae5547958d72f7f748779d3a/82871b0a56864780a70e9106d8e05ac0.jpg, createdBy=68215628101, createdName=ms3000000528368992, createdTime=Tue May 09 15:04:56 CST 2023, time=2023-05-09, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2117195, encodeId=b134211e1958c, content=感觉是内部特供，有成功的先例嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a82b5450835, createdName=osmataku, createdTime=Thu Mar 02 11:04:51 CST 2023, time=2023-03-02, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2096628, encodeId=8d6c2096628dd, content=审稿速度:2.0 | 投稿命中率:95.0 经验分享：点赞, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=220, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=90fb5469612, createdName=哈哈哈111, createdTime=Fri Oct 28 10:30:33 CST 2022, time=2022-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226380, encodeId=61371226380ba, content=目前大都是nejm的transfer文章, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=438, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a82b5450835, createdName=osmataku, createdTime=Tue Jun 14 14:04:48 CST 2022, time=2022-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1240257, encodeId=3971124025ea7, content=收不收meta分析啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=323, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5e7a5327063, createdName=148bf3b8m15暂无昵称, createdTime=Mon Aug 22 12:06:29 CST 2022, time=2022-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1240764, encodeId=8f871240e6480, content=厉害, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=343, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d816523541, createdName=ms7000000945555678, createdTime=Wed Aug 24 19:00:01 CST 2022, time=2022-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1239647, encodeId=d99b123964e36, content=稿费可观吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=319, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ba988244399, createdName=兰医生, createdTime=Fri Aug 19 05:07:27 CST 2022, time=2022-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207962, encodeId=ebdf120e962bf, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：meta分析;医学综合;临床试验 经验分享：这是NEJM旗下的新刊，刚刚出版，不过因为NEJM这个高贵血统，估计会有不少文章投NEJM后建议转投到这里。初步看了一些文章，质量还是相当不错的，未来估计影响因子在10-20分之间，不要因为现在没有IF就不投了，毕竟是名门贵族！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=421, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=医者仁者, createdTime=Fri Apr 01 21:27:28 CST 2022, time=2022-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233662, encodeId=c05112336621d, content=eee, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=345, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220719/78e45345e7a54aa7965f216022201f0f/f7c753494cda4f2f866bc9105db59a65.png, createdBy=155c5510995, createdName=YaliMei, createdTime=Wed Jul 20 17:07:54 CST 2022, time=2022-07-20, status=1, ipAttribution=)]

2022-08-19 兰医生

稿费可观吗

319 0

[GetPortalCommentsPageByObjectIdResponse(id=2184987, encodeId=377f218498e43, content=审稿速度:2.0 经验分享：什么时候有影响因子？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4d7d70412, createdName=15014e5643m, createdTime=Wed Jan 31 08:57:19 CST 2024, time=2024-01-31, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2131150, encodeId=192b213115024, content=11, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220127/d05bb6afae5547958d72f7f748779d3a/82871b0a56864780a70e9106d8e05ac0.jpg, createdBy=68215628101, createdName=ms3000000528368992, createdTime=Tue May 09 15:04:56 CST 2023, time=2023-05-09, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2117195, encodeId=b134211e1958c, content=感觉是内部特供，有成功的先例嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a82b5450835, createdName=osmataku, createdTime=Thu Mar 02 11:04:51 CST 2023, time=2023-03-02, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2096628, encodeId=8d6c2096628dd, content=审稿速度:2.0 | 投稿命中率:95.0 经验分享：点赞, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=220, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=90fb5469612, createdName=哈哈哈111, createdTime=Fri Oct 28 10:30:33 CST 2022, time=2022-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226380, encodeId=61371226380ba, content=目前大都是nejm的transfer文章, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=438, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a82b5450835, createdName=osmataku, createdTime=Tue Jun 14 14:04:48 CST 2022, time=2022-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1240257, encodeId=3971124025ea7, content=收不收meta分析啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=323, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5e7a5327063, createdName=148bf3b8m15暂无昵称, createdTime=Mon Aug 22 12:06:29 CST 2022, time=2022-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1240764, encodeId=8f871240e6480, content=厉害, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=343, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d816523541, createdName=ms7000000945555678, createdTime=Wed Aug 24 19:00:01 CST 2022, time=2022-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1239647, encodeId=d99b123964e36, content=稿费可观吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=319, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ba988244399, createdName=兰医生, createdTime=Fri Aug 19 05:07:27 CST 2022, time=2022-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207962, encodeId=ebdf120e962bf, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：meta分析;医学综合;临床试验 经验分享：这是NEJM旗下的新刊，刚刚出版，不过因为NEJM这个高贵血统，估计会有不少文章投NEJM后建议转投到这里。初步看了一些文章，质量还是相当不错的，未来估计影响因子在10-20分之间，不要因为现在没有IF就不投了，毕竟是名门贵族！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=421, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=医者仁者, createdTime=Fri Apr 01 21:27:28 CST 2022, time=2022-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233662, encodeId=c05112336621d, content=eee, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=345, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220719/78e45345e7a54aa7965f216022201f0f/f7c753494cda4f2f866bc9105db59a65.png, createdBy=155c5510995, createdName=YaliMei, createdTime=Wed Jul 20 17:07:54 CST 2022, time=2022-07-20, status=1, ipAttribution=)]

2022-04-01 医者仁者

审稿速度:3.0 | 投稿命中率:50.0
偏重的研究方向：meta分析;医学综合;临床试验
经验分享：这是NEJM旗下的新刊，刚刚出版，不过因为NEJM这个高贵血统，估计会有不少文章投NEJM后建议转投到这里。初步看了一些文章，质量还是相当不错的，未来估计影响因子在10-20分之间，不要因为现在没有IF就不投了，毕竟是名门贵族！

421 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2184987, encodeId=377f218498e43, content=审稿速度:2.0 经验分享：什么时候有影响因子？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4d7d70412, createdName=15014e5643m, createdTime=Wed Jan 31 08:57:19 CST 2024, time=2024-01-31, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2131150, encodeId=192b213115024, content=11, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220127/d05bb6afae5547958d72f7f748779d3a/82871b0a56864780a70e9106d8e05ac0.jpg, createdBy=68215628101, createdName=ms3000000528368992, createdTime=Tue May 09 15:04:56 CST 2023, time=2023-05-09, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2117195, encodeId=b134211e1958c, content=感觉是内部特供，有成功的先例嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a82b5450835, createdName=osmataku, createdTime=Thu Mar 02 11:04:51 CST 2023, time=2023-03-02, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2096628, encodeId=8d6c2096628dd, content=审稿速度:2.0 | 投稿命中率:95.0 经验分享：点赞, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=220, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=90fb5469612, createdName=哈哈哈111, createdTime=Fri Oct 28 10:30:33 CST 2022, time=2022-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226380, encodeId=61371226380ba, content=目前大都是nejm的transfer文章, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=438, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a82b5450835, createdName=osmataku, createdTime=Tue Jun 14 14:04:48 CST 2022, time=2022-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1240257, encodeId=3971124025ea7, content=收不收meta分析啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=323, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5e7a5327063, createdName=148bf3b8m15暂无昵称, createdTime=Mon Aug 22 12:06:29 CST 2022, time=2022-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1240764, encodeId=8f871240e6480, content=厉害, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=343, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d816523541, createdName=ms7000000945555678, createdTime=Wed Aug 24 19:00:01 CST 2022, time=2022-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1239647, encodeId=d99b123964e36, content=稿费可观吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=319, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ba988244399, createdName=兰医生, createdTime=Fri Aug 19 05:07:27 CST 2022, time=2022-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207962, encodeId=ebdf120e962bf, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：meta分析;医学综合;临床试验 经验分享：这是NEJM旗下的新刊，刚刚出版，不过因为NEJM这个高贵血统，估计会有不少文章投NEJM后建议转投到这里。初步看了一些文章，质量还是相当不错的，未来估计影响因子在10-20分之间，不要因为现在没有IF就不投了，毕竟是名门贵族！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=421, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=医者仁者, createdTime=Fri Apr 01 21:27:28 CST 2022, time=2022-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233662, encodeId=c05112336621d, content=eee, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=345, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220719/78e45345e7a54aa7965f216022201f0f/f7c753494cda4f2f866bc9105db59a65.png, createdBy=155c5510995, createdName=YaliMei, createdTime=Wed Jul 20 17:07:54 CST 2022, time=2022-07-20, status=1, ipAttribution=)]

2022-07-20 YaliMei

eee

345 1

展开1条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务